| Promising responses seen with Agios leukemia drug in study | | | (Reuters) - Nearly a third of patients with an advanced form of a fast-progressing leukemia who carry a specific genetic mutation experienced a complete or near complete response to an experimental Agios Pharmaceuticals drug, according to data from an early stage trial released on Monday. |
| |
| Medical lab trade group sues over U.S. reimbursement cuts | | | (Reuters) - A U.S. trade association representing medical laboratories filed a lawsuit on Monday challenging a new reimbursement system used by the federal government that it said would reduce how much Medicare pays for labs by about $670 million in 2018. |
| |
| | |
